Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Hypoxia × Blood Specimen Collection × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasms 41 Breast Neoplasms 38 Lung Neoplasms 26 Colorectal Neoplasms 21 Carcinoma, Non-Small-Cell Lung 19 Prostatic Neoplasms 13 Ovarian Neoplasms 13 Melanoma 12 Pancreatic Neoplasms 11 Neoplasm Metastasis 9 Neoplastic Cells, Circulating 8 Multiple Myeloma 8 Head and Neck Neoplasms 8 Glioblastoma 8 Uterine Cervical Neoplasms 7 Sarcoma 7 Hematologic Neoplasms 7 Glioma 7 Colonic Neoplasms 7 Lymphoma 6 Leukemia, Myeloid, Acute 6 Carcinoma, Hepatocellular 6 Disease 5 Urinary Bladder Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 4 Peritoneal Neoplasms 4 Lymphoma, Follicular 4 Leukemia 4 Kidney Neoplasms 4 Hodgkin Disease 4

Interventions

fluoroazomycin arabinoside 3 3-fluoro-2-(4-((2-nitro-1H-imidazol-1-yl)methyl)-1H-1,2,3-triazol-1-yl)propan-1-ol 3 pimonidazole 2 Propofol 2 gadobutrol 1 Sevoflurane 1 Radiotherapy 1 Pancreaticoduodenectomy 1 Oxygen 1 Ketamine 1 Gemcitabine 1 Furosemide 1 Exercise 1 Diagnostic Imaging 1 Blood Specimen Collection 1 Biopsy 1 4-methylbenzenesulfonic acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02157246 2017-03-13

RHYTHM-I

University of Oxford

Phase NA Completed

Gastrointestinal

Hypoxia, Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡